Responses
Clinical/translational cancer immunotherapy
Original research
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
Compose a Response to This Article
Other responses
No responses have been published for this article.